Stay updated on Faricimab in Diabetic Macular Edema Clinical Trial
Sign up to get notified when there's something new on the Faricimab in Diabetic Macular Edema Clinical Trial page.

Latest updates to the Faricimab in Diabetic Macular Edema Clinical Trial page
- Check3 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the usual content and indicating restricted access to the study record. This reflects an access issue that prevents viewing the trial details.SummaryDifference19%

- Check10 days agoChange DetectedAdds a new bibliographic citation listing authors and a forthcoming Ophthalmol Ther article on intraretinal fluid reduction and vision gains in diabetic macular edema, providing a new source connected to the study topic.SummaryDifference0.0%

- Check17 days agoChange DetectedRevision: v3.7.0 was added and Revision: v3.6.6 was removed to reflect a new page revision. This is a metadata tag update and does not alter the substantive content or user interactions on the page.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded a 2017 NIH grant/contract note to the study details. Updated the page revision from v3.6.5 to v3.6.6.SummaryDifference0.0%

- Check45 days agoChange DetectedTwo site-wide notices were removed: the 'Notice' header and a message about intermittent delays in some NCBI services. This affects only general messaging and does not modify the study content or data on the page.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page now provides access to key study documents and IPD sharing details and lists all study sites, reflecting a more complete study record; an error page that previously appeared has been removed.SummaryDifference100%

Stay in the know with updates to Faricimab in Diabetic Macular Edema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Faricimab in Diabetic Macular Edema Clinical Trial page.